Post-EMT: Cadherin-11 mediates cancer hijacking fibroblasts
W. Kang, Y. Fan, Y. Du, E. A. Tonkova, Y.-H. Hsu, K. V. Tan, S. Alexander, B. S. Wong, H. Yang, J. Luo, K. Yao, J. Yang, X. Hu, T. Liu, Y. Gan, J. Zhang, J. J. Zhao, K. Konstantopoulos, P. Friedl, P. L. Khong, A. Lu, M.-C. Hung, M. B. Brenner, J. E. Segall, Z. Gu
Abstract
Current prevailing knowledge on EMT (epithelial mesenchymal transition) deems epithelial cells acquire the characters of mesenchymal cells to be capable of invading and metastasizing on their own. One of the signature events of EMT is called "cadherin switch", e.g. the epithelial E-cadherin switching to the mesenchymal Cadherin-11. Here, we report the critical events after EMT that cancer cells utilize cadherin-11 to hijack the endogenous cadherin-11 positive fibroblasts. Numerous 3-D cell invasion assays with high-content live cell imaging methods reveal that cadherin-11 positive cancer cells adhere to and migrate back and forth dynamically on the cell bodies of fibroblasts. By adhering to fibroblasts for co-invasion through 3-D matrices, cancer cells acquire higher invasion speed and velocity, as well as significantly elevated invasion persistence, which are exclusive characteristics of fibroblast invasion. Silencing cadherin-11 in cancer cells or in fibroblasts, or in both, significantly decouples such physical co-invasion. Additional bioinformatics studies and PDX (patient derived xenograft) studies link such cadherin-11 mediated cancer hijacking fibroblasts to the clinical cancer progression in human such as triple-negative breast cancer patients. Further animal studies confirm cadherin-11 mediates cancer hijacking fibroblasts in vivo and promotes significant solid tumor progression and distant metastasis. Moreover, overexpression of cadherin-11 strikingly protects 4T1-luc cells from implant rejection against firefly luciferase in immunocompetent mice. Overall, our findings report and characterize the critical post-EMT event of cancer hijacking fibroblasts in cancer progression and suggest cadherin-11 can be a therapeutic target for solid tumors with stroma. Our studies hence provide significant updates on the "EMT" theory that EMT cancer cells can hijack fibroblasts to achieve full mesenchymal behaviors in vivo for efficient homing, growth, metastasis and evasion of immune surveillance. Our studies also reveal that cadherin-11 is the key molecule that helps link cancer cells to stromal fibroblasts in the "Seed & Soil" theory. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=117 SRC="FIGDIR/small/729491v2_ufig1.gif" ALT="Figure 1"> View larger version (40K): org.highwire.dtl.DTLVardef@11317f1org.highwire.dtl.DTLVardef@88fffaorg.highwire.dtl.DTLVardef@5da692org.highwire.dtl.DTLVardef@62f6ed_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The 4T1 breast carcinoma model possesses hybrid epithelial/mesenchymal traits linked to a highly metastatic phenotype
Mary E. Herndon, Mitchell G. Ayers, … Christopher S. Stipp·Disease Models & MechanismsPeer-reviewed·Aug 6, 2024
- Extent of EMT promotes invasive, contact-induced sliding on progressively narrower fiber-like tracks
Daniel F Milano, Senthil K Muthuswamy, Anand R Asthagiri·bioRxiv·Mar 19, 2016
- Dual role of E-cadherin in the regulation of invasive collective migration of mammary carcinoma cells
Y. Elisha, V. Kalchenko, … B. Geiger·bioRxiv·Jun 18, 2017
- Adhesion to type I collagen fibrous gels induces E- to N- cadherin switching without other EMT-related phenotypes in lung carcinoma cell A549
H. Fujisaki, S. Futaki, … S. Hattori·bioRxiv·Oct 2, 2020
- EMT and cell cycle control invadopodia and metastasis in breast cancer via Filip1L
Elizaveta Belova, Afrooz Jarrah, … Bojana Gligorijevic·bioRxiv·Apr 7, 2026
- Modeling the effects of EMT-immune dynamics on epithelial cancer progression
Daniel R. Bergman, Matthew K. Karikomi, … Adam L. MacLean·bioRxiv·May 30, 2020